IGFBP2 and breast carcinoma: In this study we have shown that glucose-induced IGFBP-2 secretion promoted resistance of breast cancer cells to chemotherapy; whether or not the RGD motif in IGFBP-2 is responsible for these actions is still unclear and needs further investigation.